- Home
- NSA vs SLNO Comparison
NSA vs SLNO Comparison
Compare NSA & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSA
- SLNO
- Stock Information
- Founded
- NSA 2013
- SLNO 1999
- Country
- NSA United States
- SLNO United States
- Employees
- NSA N/A
- SLNO N/A
- Industry
- NSA Real Estate Investment Trusts
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NSA Real Estate
- SLNO Health Care
- Exchange
- NSA Nasdaq
- SLNO Nasdaq
- Market Cap
- NSA 2.7B
- SLNO 2.3B
- IPO Year
- NSA 2015
- SLNO 2014
- Fundamental
- Price
- NSA $36.76
- SLNO $69.98
- Analyst Decision
- NSA Hold
- SLNO Strong Buy
- Analyst Count
- NSA 10
- SLNO 8
- Target Price
- NSA $41.28
- SLNO $95.75
- AVG Volume (30 Days)
- NSA 885.3K
- SLNO 2.6M
- Earning Date
- NSA 05-05-2025
- SLNO 05-08-2025
- Dividend Yield
- NSA 6.21%
- SLNO N/A
- EPS Growth
- NSA N/A
- SLNO N/A
- EPS
- NSA 1.18
- SLNO N/A
- Revenue
- NSA $754,260,000.00
- SLNO N/A
- Revenue This Year
- NSA N/A
- SLNO N/A
- Revenue Next Year
- NSA $3.47
- SLNO N/A
- P/E Ratio
- NSA $31.15
- SLNO N/A
- Revenue Growth
- NSA N/A
- SLNO N/A
- 52 Week Low
- NSA $30.88
- SLNO $36.61
- 52 Week High
- NSA $49.44
- SLNO $74.00
- Technical
- Relative Strength Index (RSI)
- NSA 51.33
- SLNO 62.10
- Support Level
- NSA $30.88
- SLNO $57.01
- Resistance Level
- NSA $34.99
- SLNO $71.00
- Average True Range (ATR)
- NSA 1.75
- SLNO 5.29
- MACD
- NSA 0.04
- SLNO -0.08
- Stochastic Oscillator
- NSA 66.44
- SLNO 76.34
About NSA National Storage Affiliates Trust of Beneficial Interest
National Storage Affiliates Trust Trust is a real estate investment trust. The company owns, operates, and acquires self-storage properties located within the metropolitan statistical areas throughout the United States. With the help of property management platform, the company manages and controls the day-to-day operations and affairs of consolidated properties and unconsolidated real estate ventures under the iStorage, SecurCare, RightSpace, Northwest and Move It brands.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.